Ind Swift Laboratories : Re-appointment

Ref.: ISLL:CH:2022	Date: 10th August, 2022
The President,	The Vice President,
Listing Compliance Department	Listing Compliance Department,
Bombay Stock Exchange Limited,	National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers,	Exchange Plaza, 5th Floor,
25th Floor, Dalal Street,	Plot No.C/2, G-Block,
Mumbai 400 001	Bandra Kurla Complex, Bandra (E),
	Mumbai 400 051
BSE Scrip Code: 532305	NSE Symbol: INDSWFTLAB

SUB: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for re-appointment of the Mr. Rishav Mehta as Executive Director;

Dear Sir,

Pursuant to the provisions of Regulation 30 and any other applicable provisions, if any, of the Securities and Exchange of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (hereinafter "SEBI Listing Regulations") please note that the Board of Directors in their meeting held on today i.e. 10th August, 2022, have considered and approved the reappointment of and payment of remuneration to Mr. Rishav Mehta (DIN: 00015407), Executive Director of the company for a period of next five years w.e.f. 23rd March, 2023 as recommended by Nomination and Remuneration Committee, Subject to the approval of the Shareholders of the Company.

Pursuant to the SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, the brief profile of the Mr. Rishav Mehta is enclosed herewith.

You are requested to kindly take the same on record.

Thanking you,

Encl: As above

BRIEF PROFILE OF MR. RISHAV MEHTA EXECUTIVE DIRECTOR

	Name of the Director		Mr. Rishav Mehta (DIN: 00015407)
	Date of re-appointment		The Current term of Mr. Rishav Mehta Executive
			Director is going to expire on 22nd March 2023.
			Mr. Rishav Mehta has been proposed to be
			reappointed as Executive Director of the
			Company for a period of next five year w.e.f 23rd
			March 2023 subject to the approval of
			shareholder in Ensuing Annual General meeting.
	Type		Executive Director
	Age		31 Years
	Date of Appointment		Re-appointment with effect from 23rd March,
		2023.
	Qualification		Graduate
	Expertise		Mr. Rishav Mehta, Executive Director, Ind-Swift
			Laboratories Ltd. is having over eight years of
			experience in pharmaceutical industry, project
			planning & control. He is playing active role in
			production management and development of
			new generic products.
	Directorships held in other Companies		IND SWIFT LIMITED
			DASHMESH MEDICARE PRIVATE LIMITED
			ESSIX BIOSCIENCES LIMITED
			VIBRANT AGRO INDUSTRIES LIMITED
	No. of Equity Shares held in the Company		4,54,545 equity shares of Rs. 10 each
	Information as required pursuant to BSE Circular		Mr. Rishav Mehta is not debarred from holding
	with ref. no. LIST/COMP/14/2018-19		the office of director by virtue of any SEBI order or
			any other such authority.
	Relationship Between Directors/ KMP inter-se		Mr. Rishav Mehta is not related to any other
			Director of the Company